Franca Guerini

Dr. Franca Guerini

IRCCS Fondazione Don Carlo Gnocchi
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2018 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SASimone Agostini
Simone Agostini
RMRoberta Mancuso
Roberta Mancuso
FGFranca Guerini
Franca Guerini
UDUmberto Dianzani
Umberto Dianzani
CACristina Agliardi
Cristina Agliardi
mario clericimario clerici
mario clerici
The etiopathology of multiple sclerosis (MS) is believed to include genetic and environmental factors. Human leukocyte antigen (HLA) alleles, in particular, are associated with disease susceptibility, whereas Epstein Barr Virus (EBV) infection has long been suspected to play a role in disease pathogenesis. The aim of the present study is to evaluate correlations between HLA alleles and EBV infection in MS. HLA alleles, EBV viral load (VL) and serum anti-EBV antibody titers were evaluated in EBV-seropositive MS patients (N = 117) and age- and sex-matched healthy controls (HC; N = 89). Significantly higher DNA viral loads (p = 0.048) and EBNA-1 antibody titer (p = 0.0004) were seen in MS compared to HC. EBV VL was higher in HLA-B*07+ (p = 0.02) and HLA-DRB1*15+ (p = 0.02) MS patients, whereas it was lower in HLA-A*02+ (p = 0.04) subjects. EBV VL was highest in HLA-A*02−/B*07+/DRB1*15+ patients and lowest in HLA-A*A02+/B*07−/DRB1*15− individuals (p < 0.0001). HLA-B*07 resulted the most associated allele to EBV VL after multiple regression analysis considering altogether the three alleles, (p = 0.0001). No differences were observed in anti-EBV antibody titers in relationship with HLA distribution. Host HLA-B*07 allele influence EBV VL in MS. As HLA-class I molecules present antigens to T lymphocytes and initiate immune response against viruses, these results could support a role for EBV in MS.

15 October 2009 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
FGFranca Guerini
Franca Guerini
EBE. Beghi
E. Beghi
GRG. Riboldazzi
G. Riboldazzi
RZR. Zangaglia
R. Zangaglia
CPC. Pianezzola
C. Pianezzola
EME. Martignoni
E. Martignoni

Verified
Journal Article
Open access
PDF file
CPCristina Panisi
Cristina Panisi
FGFranca Guerini
Franca Guerini
PAProvvidenza Maria Abruzzo
Provvidenza Maria Abruzzo
FBFederico Balzola
Federico Balzola
Pier Mario BiavaPier Mario Biava
Pier Mario Biava
Vassilios FanosVassilios Fanos
Vassilios Fanos
The wide spectrum of unique needs and strengths of Autism Spectrum Disorders (ASD) is a challenge for the worldwide healthcare system. With the plethora of information from research, a common thread is required to conceptualize an exhaustive pathogenetic paradigm. The epidemiological and clinical findings in ASD cannot be explained by the traditional linear genetic model, hence the need to move towards a more fluid conception, integrating genetics, environment, and epigenetics as a whole. The embryo-fetal period and the first two years of life (the so-called ‘First 1000 Days’) are the crucial time window for neurodevelopment. In particular, the interplay and the vicious loop between immune activation, gut dysbiosis, and mitochondrial impairment/oxidative stress significantly affects neurodevelopment during pregnancy and undermines the health of ASD people throughout life. Consequently, the most effective intervention in ASD is expected by primary prevention aimed at pregnancy and at early control of the main effector molecular pathways. We will reason here on a comprehensive and exhaustive pathogenetic paradigm in ASD, viewed not just as a theoretical issue, but as a tool to provide suggestions for effective preventive strategies and personalized, dynamic (from womb to adulthood), systemic, and interdisciplinary healthcare approach.

26 June 2023 in Biology
Verified
Journal Article
Open access
PDF file
CACristina Agliardi
Cristina Agliardi
FGFranca Guerini
Franca Guerini
EBElisabetta Bolognesi
Elisabetta Bolognesi
MZMilena Zanzottera
Milena Zanzottera
mario clericimario clerici
mario clerici
The vitamin D/Vitamin D receptor (VDR) axis is crucial for human health as it regulates the expression of genes involved in different functions, including calcium homeostasis, energy metabolism, cell growth and differentiation, and immune responses. In particular, the vitamin D/VDR complex regulates genes of both innate and adaptive immunity. Autoimmune diseases are believed to arise from a genetic predisposition and the presence of triggers such as hormones and environmental factors. Among these, a role for Vitamin D and molecules correlated to its functions has been repeatedly suggested. Four single nucleotide polymorphisms (SNPs) of the VDR gene, ApaI, BsmI, TaqI, and FokI, in particular, have been associated with autoimmune disorders. The presence of particular VDR SNP alleles and genotypes, thus, was observed to modulate the likelihood of developing diverse autoimmune conditions, either increasing or reducing it. In this work, we will review the scientific literature suggesting a role for these different factors in the pathogenesis of autoimmune conditions and summarize evidence indicating a possible VDR SNP involvement in the onset of these diseases. A better understanding of the role of the molecular mechanisms linking Vitamin D/VDR and autoimmunity might be extremely useful in designing novel therapeutic avenues for these disorders.

Verified
Journal Article
Open access
PDF file
CACristina Agliardi
Cristina Agliardi
FGFranca Guerini
Franca Guerini
MZMilena Zanzottera
Milena Zanzottera
EBElisabetta Bolognesi
Elisabetta Bolognesi
SPSilvia Picciolini
Silvia Picciolini
mario clericimario clerici
mario clerici
Approximately 15% of multiple sclerosis (MS) patients develop a progressive form of disease from onset; this condition (primary progressive-PP) MS is difficult to diagnose and treat, and is associated with a poor prognosis. Extracellular vesicles (EVs) of brain origin isolated from blood and their protein cargoes could function as a biomarker of pathological conditions. We verified whether MBP and MOG content in oligodendrocytes-derived EVs (ODEVs) could be biomarkers of MS and could help in the differential diagnosis of clinical MS phenotypes. A total of 136 individuals (7 clinically isolated syndrome (CIS), 18 PPMS, 49 relapsing remitting (RRMS)) and 70 matched healthy controls (HC) were enrolled. ODEVs were enriched from serum by immune-capture with anti-MOG antibody; MBP and MOG protein cargoes were measured by ELISA. MBP concentration in ODEVs was significantly increased in CIS (p < 0.001), RRMS (p < 0.001) and PPMS (p < 0.001) compared to HC and was correlated with disease severity measured by EDSS and MSSS. Notably, MBP concentration in ODEVs was also significantly augmented in PPMS compared to RRMS (p = 0.004) and CIS (p = 0.03). Logistic regression and ROC analyses confirmed these results. A minimally invasive blood test measuring the concentration of MBP in ODEVs is a promising tool that could facilitate MS diagnosis.

1 September 2011 in Pharmacological Research
Verified
Journal Article
Closed access
FGFranca Guerini
Franca Guerini
EBElisabetta Bolognesi
Elisabetta Bolognesi
MCMatteo Chiappedi
Matteo Chiappedi
SMSalvatorica Manca
Salvatorica Manca
AGAlessandro Ghezzo
Alessandro Ghezzo
mario clericimario clerici
mario clerici